Surgery for migraines – an update

August 2, 2009

In my post 2 years ago I wrote about surgery for migraines and the many reasons why Botox injections is a better option than surgery to permanently cut nerves and muscles. I also wrote that there were no controlled studies to show that surgery actually works. Now we do have one study. The study was blinded, which means that some patients had nerves and muscles cut, while others had only a skin incision. The results were much better in patients who had real surgery. The plastic surgeons who performed the study tried their best to produce a blinded study, but they admit that blinding is far from perfect since patients who had real surgery can see their muscles shrink or not move. But even if we accept that blinding was achieved and surgery indeed provides relief of headaches, all of my other arguments stand. These include surgical risks (bleeding, infection, scarring, and persistent nerve pain) and high cost. Yes, Botox is expensive too, but migraine usually is not a life-long illness and migraine attacks often stop for long periods of time or permanently with or even without treatment. I have seen many patients whom I treated with Botox every 3 months and whose headaches stop after a year or two. Two years of Botox treatments is significantly cheaper than surgery and it does not carry all of the surgical risks.

Written by
Alexander Mauskop, MD
Continue reading
August 8, 2026
Sugar is bad for your brain, even before you are born.
Sugar consumed in the first two years of life increases the risk of dementia.
Read article
August 6, 2026
Research
An Old Medicine that Could Make Brain Stimulation Work Better for Depression and Other Neurological Conditions
A 2022 clinical trial from the University of Calgary found that adding low‑dose D‑cycloserine (DCS), a partial NMDA‑receptor agonist, to intermittent theta‑burst stimulation (iTBS) significantly increased response and remission rates in depression without serious side effects. Early follow‑up data suggest that timing, dose, and drug levels matter, and raise the possibility that this DCS‑TMS approach could eventually be applied to other neurological conditions—such as migraine, postconcussion syndrome, brain fog, and long COVID
Read article
Insights from Dr. Alexander Mauskop on headaches and migraines
Subscribe to the Blog.
Subscribe
Subscribe